Kotak Healthcare Fund

Kotak Mahindra Mutual FundThematicPortfolio as of 31 July 2026

Kotak Healthcare Fund holds 34 instruments (98.73% equity), led by Sun Pharmaceutical Industries Limited (14.88%), Divi's Laboratories Limited (8.26%) and Torrent Pharmaceuticals Limited (6.16%), as of its 31 July 2026 SEBI-mandated monthly disclosure.

Holdings
34
Equity Allocation
98.73%
AMC
Kotak Mahindra Mutual Fund
Category
Thematic

This page shows the complete disclosed portfolio of Kotak Healthcare Fund, managed by Kotak Mahindra Mutual Fund, based on its monthly portfolio disclosure dated 31 July 2026. The fund holds 34 instruments with an equity allocation of 98.73%. Percentages are of net assets (% to NAV). Click any stock to see every other mutual fund that also holds it.

Portfolio Analysis

Kotak Healthcare Fund's top 10 holdings account for 56.75% of its portfolio, more concentrated than the Thematic category average of 50.4%. Healthcare is its largest sector exposure at 96.9% of net assets, spread across 2 sectors in total. Since its 30 June 2026 disclosure, the fund added 2 new positions and exited 4 positions, with Divi's Laboratories Limited seeing the largest move (+2.93pp to 8.26%).

Top 10 Equity Holdings

What Changed: June 2026 → July 2026

Equity holdings compared between the fund's two latest monthly disclosures. Weights are % to NAV; weight moves can also reflect price changes, not only buying or selling.

2 new entries4 exits10 increased10 reduced

Biggest Weight Increases

StockWeightChange
Divi's Laboratories Limited5.33% → 8.26%▲ +2.93
Sun Pharmaceutical Industries Limited13.73% → 14.88%▲ +1.15
Gland Pharma Limited2.21% → 2.75%▲ +0.54
Laurus Labs Limited2.24% → 2.66%▲ +0.42
Emcure Pharmaceuticals Limited1.49% → 1.87%▲ +0.38
Sai Life Sciences Limited2.91% → 3.08%▲ +0.17
Dr. Lal Path Labs Ltd.1.07% → 1.23%▲ +0.16
Orchid Pharma Limited1.72% → 1.88%▲ +0.16
CORONA Remedies Limited1.74% → 1.85%▲ +0.11
Rubicon Research Limited2.07% → 2.18%▲ +0.11

Biggest Weight Reductions

StockWeightChange
Lupin Limited2.32% → 1.42%▼ -0.9
Acutaas Chemicals Limited5.2% → 4.32%▼ -0.88
Max Healthcare Institute Limited5.99% → 5.15%▼ -0.84
Aurobindo Pharma Limited2.33% → 1.62%▼ -0.71
Fortis Healthcare Limited4.02% → 3.46%▼ -0.56
Jubilant Pharmova Limited1.93% → 1.37%▼ -0.56
Zydus Lifesciences Limited1.64% → 1.24%▼ -0.4
Laxmi Dental Limited0.95% → 0.64%▼ -0.31
Yatharth Hospital & Trauma Care Services Limited3.15% → 2.99%▼ -0.16
Krishna Institute of Medical Sciences Limited3.09% → 2.95%▼ -0.14

Top Holdings — Weight Trend

% to NAV of the fund's current top holdings over its last 6 monthly disclosures (Feb – Jul 2026).

Feb: 12.53%, Mar: 13.91%, Apr: 14.04%, May: 13.01%, Jun: 13.73%, Jul: 14.88%
14.88%
Feb: 5.94%, Mar: 6.05%, Apr: 5.9%, May: 5.95%, Jun: 5.33%, Jul: 8.26%
8.26%
Feb: 7.31%, Mar: 6.96%, Apr: 6.31%, May: 5.43%, Jun: 5.99%, Jul: 5.15%
5.15%
Feb: 4%, Mar: 5.09%, Apr: 4.6%, May: 4.92%, Jun: 5.2%, Jul: 4.32%
4.32%

Full Portfolio (34 holdings)

#HoldingSector% to NAV
1Sun Pharmaceutical Industries LimitedHealthcare14.88%
2Divi's Laboratories LimitedHealthcare8.26%
3Torrent Pharmaceuticals LimitedHealthcare6.16%
4Max Healthcare Institute LimitedHealthcare5.15%
5Acutaas Chemicals LimitedHealthcare4.32%
6Cipla LimitedHealthcare4.32%
7Park Medi World LimitedHealthcare3.86%
8Fortis Healthcare LimitedHealthcare3.46%
9Mankind Pharma LimitedHealthcare3.26%
10Sai Life Sciences LimitedHealthcare3.08%
11Yatharth Hospital & Trauma Care Services LimitedHealthcare2.99%
12Krishna Institute of Medical Sciences LimitedHealthcare2.95%
13Gland Pharma LimitedHealthcare2.75%
14Laurus Labs LimitedHealthcare2.66%
15Apollo Hospitals Enterprise LimitedHealthcare2.63%
16Anthem Biosciences LimitedHealthcare2.37%
17Ajanta Pharma LimitedHealthcare2.29%
18Marksans Pharma LimitedHealthcare2.27%
19Rubicon Research LimitedHealthcare2.18%
20Orchid Pharma LimitedHealthcare1.88%
21Emcure Pharmaceuticals LimitedHealthcare1.87%
22CORONA Remedies LimitedHealthcare1.85%
23Jubilant Ingrevia LimitedMaterials1.83%
24Aurobindo Pharma LimitedHealthcare1.62%
25Rainbow Childrens Medicare LimitedHealthcare1.56%
26Triparty Repotreps1.54%
27Lupin LimitedHealthcare1.42%
28Jubilant Pharmova LimitedHealthcare1.37%
29Metropolis Healthcare LimitedHealthcare1.28%
30Zydus Lifesciences LimitedHealthcare1.24%
31Dr. Lal Path Labs Ltd.Healthcare1.23%
32Innova Captab LimitedHealthcare1.1%
33Laxmi Dental LimitedHealthcare0.64%
34Net Current Assets/(Liabilities)other-0.27%

Frequently Asked Questions

Yes. As of its 31 July 2026 disclosure, Sun Pharmaceutical Industries Limited is 14.88% of Kotak Healthcare Fund's net assets — its number 1 holding.
Yes. As of its 31 July 2026 disclosure, Divi's Laboratories Limited is 8.26% of Kotak Healthcare Fund's net assets — its number 2 holding.
Yes. As of its 31 July 2026 disclosure, Torrent Pharmaceuticals Limited is 6.16% of Kotak Healthcare Fund's net assets — its number 3 holding.
Yes. As of its 31 July 2026 disclosure, Max Healthcare Institute Limited is 5.15% of Kotak Healthcare Fund's net assets — its number 4 holding.
Yes. As of its 31 July 2026 disclosure, Acutaas Chemicals Limited is 4.32% of Kotak Healthcare Fund's net assets — its number 5 holding.

New to reading these? See How to Read a Mutual Fund's Monthly Portfolio Disclosure, or check terms like % to NAV in the glossary.

Source: Kotak Mahindra Mutual Fund's SEBI-mandated monthly portfolio disclosure, dated 31 July 2026. Data is for information only, not investment advice. Holdings may have changed since the disclosure date.